Source: MarketScreener

Arix Bioscience: RTW Biotech agrees "immediately accretive" Arix Bioscience takeover

(marketscreener.com) RTW Biotech Opportunities Ltd on Wednesday said it has agreed to acquire all the assets of fellow London listing Arix Bioscience PLC in exchange for new RTW shares, and to buy a 25.5% stake from Arix's largest shareholder in cash. Shares in RTW Biotech were down 3.9% at USD1.10 in London on Wednesday. Arix shares were down 1.1% at 116.70 pence...https://www.marketscreener.com/quote/stock/ARIX-BIOSCIENCE-PLC-34067690/news/RTW-Biotech-agrees-immediately-accretive-Arix-Bioscience-takeover-45210482/?utm_medium=RSS&utm_content=20231101

Read full article »
Annual Revenue
$100K-5.0M
Employees
1-25
Robert Lyne's photo - CEO of Arix

CEO

Robert Lyne

CEO Approval Rating

85/100

Read more